1 INTRODUCTION Achondroplasia (ACH) is the most frequent skeletal dysplasia associated with disproportionate short stature (Horton et al., 2007). ACH occurs in ~1 in 10,000 to 30,000 live births, regardless of sex or genetic ancestry (Savarirayan et al., 2022). The molecular basis of ACH was elucidated in 1994 as a heterozygous pathogenic variant in the fibroblast growth factor receptor 3 (FGFR3) gene on chromosome 4p16.3 (Rousseau et al., 1994; Shiang et al., 1994).